PTH and osteoporosis: Majority of the existing treatments for osteoporosis such as recombinant parathyroid hormone (PTH) [4], bisphosphonates [5], and selective estrogen receptor modulators (SERMS) [6,7] have multiple side effects [8] and new therapeutics are desperately needed.